The global patent landscape of mRNA for diagnosis and therapy
Nat Biotechnol
.
2023 Sep;41(9):1193-1199.
doi: 10.1038/s41587-023-01925-2.
Authors
Mengru Lyu
#
1
2
,
Jiyuan Chen
#
3
,
Yeheng Peng
#
1
,
Fang Han
2
,
Luyao Gong
1
,
Jingfei Guo
2
,
Lijuan Tian
2
,
Yuan Gao
4
Affiliations
1
Department of Clinical Pharmacy and Pharmaceutical Management, School of Pharmacy, Fudan University, Shanghai, China.
2
Department of Clinical Pharmacy, School of Life Sciences and Biopharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang, China.
3
Department of Pharmacy, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
4
Department of Clinical Pharmacy and Pharmaceutical Management, School of Pharmacy, Fudan University, Shanghai, China. yuan_gao@fudan.edu.cn.
#
Contributed equally.
PMID:
37699990
DOI:
10.1038/s41587-023-01925-2
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Patents as Topic*
RNA, Messenger*
Substances
RNA, Messenger